Review of Outcomes after Salvage Surgery for Recurrent Squamous Cell Carcinoma of the Head and Neck.
Dana M HartlJoanne GuerlainPhilippe GorpheMadan KapreNeeti Kapre GuptaNabil F SabaK Thomas RobbinsOhad RonenJuan Pablo RodrigoPrimoz StrojanAntti A MäkitieLuiz Paulo KowalskiJatin P ShahAlfio FerlitoPublished in: Cancers (2023)
Surgery with adjuvant chemoradiotherapy or chemoradiotherapy is the mainstay in treatment for advanced stage head and neck squamous cell carcinoma; however, locoregional recurrences are frequent. Salvage surgery could be proposed in selected patients to improve local control, disease-free, and overall survival. Factors for improved disease-free and overall survival in patients treated with salvage surgery include age, tumor location, the initial T stage, HPV status, resection margins, and the time elapsing from the initial treatment. Clinical trials with adjuvant therapies have shown promise after salvage surgery in terms of tolerance and response, but clinical guidelines for using these adjuvant treatments are currently lacking. The aim of this review is to present current knowledge concerning the incidence and management of recurrent head and neck squamous cell carcinoma and current data concerning survival and morbidity after salvage surgery.
Keyphrases
- minimally invasive
- coronary artery bypass
- squamous cell carcinoma
- clinical trial
- surgical site infection
- early stage
- healthcare
- percutaneous coronary intervention
- newly diagnosed
- risk factors
- big data
- acute coronary syndrome
- ejection fraction
- radiation therapy
- atrial fibrillation
- study protocol
- patient reported outcomes
- lymph node metastasis